← Back to CEO Rankings
Christopher Boerner

Christopher Boerner

Bristol Myers Squibb (BMY)
Healthcare
🏢 CEO since 2015 · 11 years
+14.9%
1-Year Stock Performance
$71.0M
2024 Compensation
😊 Positive
News Sentiment

Employment History

Company Role Years
Bristol Myers Squibb CEO 2015–2023
Bristol Myers Squibb COO 2013–2015
Bristol Myers Squibb Commercial leadership roles 2000–2013

Education

Institution Degree Year
Sapienza University of Rome MD 1988

Latest News

Limited recent coverage. Includes older articles for context.
Bristol Myers Squibb
neutral

Chris Boerner, Board Chair and Chief Executive Officer - Bristol Myers Squibb

Chris Boerner, Board Chair and Chief Executive Officer  Bristol Myers Squibb...

Jun 16, 2026 Read More →
BBN Times
neutral

Christopher Boerner: Biopharma Strategist, Commercial Innovator, and Chairman and CEO of Bristol Myers Squibb - BBN Times

Christopher Boerner: Biopharma Strategist, Commercial Innovator, and Chairman and CEO of Bristol Myers Squibb  BBN Times...

Jun 4, 2026 Read More →
Endpoints News
neutral

Bristol Myers turns focus to AI costs after broad rollout to workers - Endpoints News

Bristol Myers turns focus to AI costs after broad rollout to workers  Endpoints News...

Jun 3, 2026 Read More →
CNBC
neutral

Bristol Myers Squibb CEO on cancer developments in the pipeline - CNBC

Bristol Myers Squibb CEO on cancer developments in the pipeline  CNBC...

Jun 1, 2026 Read More →
Stanford Medicine
neutral

Chris Boerner - Stanford Medicine

Chris Boerner  Stanford Medicine...

May 30, 2026 Read More →